» Articles » PMID: 18058037

Structural Genomics of Protein Phosphatases

Abstract

The New York SGX Research Center for Structural Genomics (NYSGXRC) of the NIGMS Protein Structure Initiative (PSI) has applied its high-throughput X-ray crystallographic structure determination platform to systematic studies of all human protein phosphatases and protein phosphatases from biomedically-relevant pathogens. To date, the NYSGXRC has determined structures of 21 distinct protein phosphatases: 14 from human, 2 from mouse, 2 from the pathogen Toxoplasma gondii, 1 from Trypanosoma brucei, the parasite responsible for African sleeping sickness, and 2 from the principal mosquito vector of malaria in Africa, Anopheles gambiae. These structures provide insights into both normal and pathophysiologic processes, including transcriptional regulation, regulation of major signaling pathways, neural development, and type 1 diabetes. In conjunction with the contributions of other international structural genomics consortia, these efforts promise to provide an unprecedented database and materials repository for structure-guided experimental and computational discovery of inhibitors for all classes of protein phosphatases.

Citing Articles

Mitochondrial Alpha-Keto Acid Dehydrogenase Complexes: Recent Developments on Structure and Function in Health and Disease.

Szabo E, Nagy B, Czajlik A, Komlodi T, Ozohanics O, Tretter L Subcell Biochem. 2024; 104:295-381.

PMID: 38963492 DOI: 10.1007/978-3-031-58843-3_13.


A novel binding pocket in the D2 domain of protein tyrosine phosphatase mu (PTPmu) guides AI screen to identify small molecules that modulate tumour cell adhesion, growth and migration.

Molyneaux K, Laggner C, Brady-Kalnay S J Cell Mol Med. 2023; 27(22):3553-3564.

PMID: 37860940 PMC: 10660673. DOI: 10.1111/jcmm.17973.


Small molecule antagonists of PTPmu identified by artificial intelligence-based computational screening block glioma cell migration and growth.

Molyneaux K, Laggner C, Vincent J, Brady-Kalnay S PLoS One. 2023; 18(7):e0288980.

PMID: 37494327 PMC: 10370706. DOI: 10.1371/journal.pone.0288980.


Synthesis and hypoglycemic activity of quinoxaline derivatives.

Jia W, Wang J, Wei C, Bian M, Bao S, Yu L Front Chem. 2023; 11:1197124.

PMID: 37483267 PMC: 10358274. DOI: 10.3389/fchem.2023.1197124.


Clustering of phosphatase RPTPα promotes Src signaling and the arthritogenic action of synovial fibroblasts.

Sendo S, Kiosses W, Yang S, Wu D, Lee D, Liu L Sci Signal. 2023; 16(792):eabn8668.

PMID: 37402225 PMC: 10544828. DOI: 10.1126/scisignal.abn8668.


References
1.
Shatkin A, Manley J . The ends of the affair: capping and polyadenylation. Nat Struct Biol. 2000; 7(10):838-42. DOI: 10.1038/79583. View

2.
Tonks N . Protein tyrosine phosphatases: from genes, to function, to disease. Nat Rev Mol Cell Biol. 2006; 7(11):833-46. DOI: 10.1038/nrm2039. View

3.
Siu R, Fladd C, Rotin D . N-cadherin is an in vivo substrate for protein tyrosine phosphatase sigma (PTPsigma) and participates in PTPsigma-mediated inhibition of axon growth. Mol Cell Biol. 2006; 27(1):208-19. PMC: 1800655. DOI: 10.1128/MCB.00707-06. View

4.
Kang M, Dahmus M . RNA polymerases IIA and IIO have distinct roles during transcription from the TATA-less murine dihydrofolate reductase promoter. J Biol Chem. 1993; 268(33):25033-40. View

5.
Rodriguez C, Cho E, Keogh M, Moore C, Greenleaf A, Buratowski S . Kin28, the TFIIH-associated carboxy-terminal domain kinase, facilitates the recruitment of mRNA processing machinery to RNA polymerase II. Mol Cell Biol. 1999; 20(1):104-12. PMC: 85066. DOI: 10.1128/MCB.20.1.104-112.2000. View